RxDoctor Payments Data

Jeremy Larson, DO

Psychiatry · St George, UTNPI 1932551801

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.8% of the total across 113 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by Johnson & Johnson at 29.8% of the total. Among psychiatry clinicians in UT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,419in general payments, 2019–2025

Across 113 payments — averaging $21.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$722
  • Otsuka America Pharmaceutical, Inc.$307
  • Braeburn Inc.$190
  • Teva Pharmaceuticals USA, Inc.$181
  • AbbVie$161
  • Sunovion Pharmaceuticals Inc.$157
  • plus $703 from 13 others

What the payments were for

  • Food & beverage$2,38999%
  • Education$301%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,419 in reported general payments places this provider in the 90th percentile of 231 psychiatry providers in Utah.

See all psychiatry providers in Utah

Medicare billing

Part B allowed, 2024
$39,009
Medicare patients
33
Services billed
394

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
DayvigoLemborexant12$3,981
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl15$3,156
Bupropion XlBupropion Hcl106$2,185
Venlafaxine Hcl ErVenlafaxine Hcl71$972
Duloxetine Hcl67$750
Sertraline Hcl33$412
Trazodone Hcl44$387
Mirtazapine26$371
Escitalopram Oxalate38$305
Doxepin Hcl24$303
Buspirone Hcl33$295
Quetiapine Fumarate19$276
Clonazepam50$269
Risperidone17$261
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine17$225

Paid to pharmacies, not to this prescriber.

Other psychiatry in St George

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →